Results 441-460 of 1,212,726 for in 'Dáil debates' OR in 'Committee meetings' (speaker:Tom Kitt OR speaker:Duncan Smith OR speaker:Cian O'Callaghan OR speaker:Denis Naughten OR speaker:Gary Gannon OR speaker:Dara Calleary OR speaker:Mark Ward OR speaker:Joe Flaherty OR speaker:Carol Nolan OR speaker:Sorca Clarke OR speaker:Roderic O'Gorman OR speaker:Michael Collins OR speaker:Claire Kerrane OR speaker:Ruairi Ó Murchú OR speaker:Thomas Gould OR speaker:Louise O'Reilly OR speaker:Niamh Smyth OR speaker:James O'Connor OR speaker:Norma Foley OR speaker:Brian Stanley OR speaker:Simon Harris OR speaker:Johnny Mythen OR speaker:Richard Boyd Barrett OR speaker:Marc Ó Cathasaigh OR speaker:Jennifer Whitmore OR speaker:James Lawless OR speaker:John Brady OR speaker:Marian Harkin OR speaker:Robert Troy OR speaker:Eoin Ó Broin OR speaker:Seán Fleming OR speaker:Danny Healy-Rae OR speaker:Matt Shanahan OR speaker:Matt Carthy OR speaker:Neale Richmond OR speaker:Catherine Connolly OR speaker:Fergus O'Dowd OR speaker:Michael Healy-Rae OR speaker:Denise Mitchell OR speaker:Micheál Martin OR speaker:Seán Crowe OR speaker:Seán Canney OR speaker:Pa Daly OR speaker:Christopher O'Sullivan OR speaker:Eamon Ryan OR speaker:Peadar Tóibín OR speaker:Pauline Tully OR speaker:Marc MacSharry OR speaker:Martin Kenny OR speaker:Thomas Pringle OR speaker:Jim O'Callaghan OR speaker:Michael Lowry OR speaker:Bríd Smith OR speaker:Cathal Berry OR speaker:Willie O'Dea OR speaker:Aindrias Moynihan OR speaker:David Cullinane OR speaker:Paul Murphy)

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Louise O'Reilly: I thank Mr. Perth for that. For the broader witnesses, my understanding is that the committee has agreed that public consumption of drugs cannot be allowed to increase, as we have heard from other jurisdictions that this has huge impacts when they decriminalise drugs. How can we control public consumption without further stigmatising the people the witnesses are working with? How can those...

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Louise O'Reilly: I agree.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Louise O'Reilly: It would be overwhelmed.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Louise O'Reilly: Specifically regarding public consumption and the way that can be managed, my understanding is the committee had agreed that an increase in public consumption should not necessarily be a by-product. How can that be done without further stigmatisation, however? We spoke about stigma and trauma. How can that be done without heaping further stigma on communities that do not need it and cannot...

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Seán Crowe: We were talking about the whole area of youth through the justice system and the lens of it. Again, it seems to be that if you are seen as a potential problem, the supports, the funding or group is there in relation to it, as Mr. Perth mentioned in his opening statement. We seem to pigeonhole young people who are a potential problem. All of a sudden, there is funding there in the justice...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: Comhghaideas leis an gCathaoirleach. I do not intend to dwell on this but I have one question about that high earner. Mr. Gloster used the word "abhorrent", with which I think most of us would agree. Are we going to face a similar scenario? He talked about the new consultant contracts and the employment of more consultants, which is the ultimate aim, but are legacy contracts in place such...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: Mr. Gloster is telling the committee he expects it to get better over time. Is that correct?

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: In the recent past, my family has been very glad to have access to consultants out of hours. I will touch on that. My father is 80 years of age. He still rides vintage motorcycles around the place, which is great for our collective family blood pressure. He gave us a bit of a scare recently. He came off the bike. We were in hospital with him. This goes back to Deputy Cannon's point...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: I will ask one more quick question and I will then move on to non-compliance. We are lucky with UHW. There are fights to be had about the provision of health services in Waterford. People will know well about the fight for 24-7 and the second cath lab. That has been well documented, but we are very lucky in that ours is one of the model 4 hospitals that does not have people on trolleys....

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: I want to deal with non-compliant procurement in the short time remaining. We are talking about a spend of €4.2 billion. The HSE has put the estimate for non-compliant spending at 12%. We have difference there because, apparently, the exercise only covered 38% of the overall spend. Could Mr. Mulvany put a monetary value on it for me because I am making an assumption - it may be...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: I guess what I am trying to get at here is whether it is 12% of the cases or 12% of the procurement-----

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: It really is a significant amount. If that maps out to the €4.2 billion, we are talking about close on €500 million that will en up being non-compliant procurement.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: If I map those trends onto the €4.2 billion, we could be talking about a sum of the order of €500 million.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: The number, which is staggering, troubles me. Something that worries me more is that one of the reasons we get back for not having that information, on the one hand, is the manager responsible for the expenditure could not be identified centrally. That would very much worry me. Then the flip side is that the identified managers failed to respond to the exercise. When they were asked about...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: If I can focus the question specifically, if a local or regional manager does not engage with Mr. Mulvany when he asks the question about non-compliant procurement, is there a sanction that follows?

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: In the context of those two things - the manager responsible could not be identified which would be on the HSE versus the person did not respond - can Mr. Mulvany provide an indication of where the balance lies?

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: Not tolerating something and not pursuing it are quite different from having a series of sanctions that apply.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Marc Ó Cathasaigh: Has that happened in any instances?